ICAAC 52nd (2012)

Title Content type
In Vitro Activity of Isavuconazole Against Cryptococcus Isolates – A Pooled Analysis of 3 Studies (click for details)
Effect of Multiple Doses of Isavuconazole on the Pharmacokinetics of CYP3A4 Substrate Midazolam in Healthy Volunteers (click for details)
Isavuconazole (ISA) Pharmacodynamic (PD) Target Determination for C. albicans (CA) in an in vivo Neutropenic Murine Model of Invasive Candidiasis (IC) (click for details)
In vitro activity of Isavuconazole against a worldwide collection of 237 Aspergillus terreus isolates and compared with 7 other Aspergillus active antifungal drugs tested with EUCAST and CLSI methodology (click for details)
Quantitative PCR Detection Of Circulating Dna In Serum For Early Diagnosis Of Mucormycosis (click for details)
Pharmacodynamic (PD) of Posaconazole (P) in a Murine Invasive Pulmonary Aspergillosis (IPA) Model Against Wild Type and Cyp51 mutant Isolates (click for details)
Increase of Candidemia due to non-albicans Candida Species in Oncohematological (OH) Patients in Spain (click for details)
Screening for New Antifungal Agents (click for details)
Pharmacodynamics of Voriconazole (VCZ) in a Novel Dynamic in vitro Model of invasive Pulmonary Aspergillosis (IPA): Implications for in vitro Susceptibility Breakpoints and Targets for therapeutic Drug Monitoring (TDM) (click for details)
Utility of BAL Galactomannan (GM) and Culture Based Pre-Emptive Antifungal Therapy (PET) Strategy in Lung Transplant Recipients (LTRs) (click for details)


Subscribe to ICAAC 52nd (2012)